She is status post recent discharge from [**Hospital1 18**] on [**4-29**] following work-up and evaluation of RUQ discomfort and fevers.
two PTBDs are in place and are capped, insertion sites are similarly intact and without evidence drainage or erythema Ext: 1+ bilateral nonpitting edema (at baseline)  Pertinent Results: [**2168-5-10**] 04:50PM BLOOD WBC-8.5 RBC-4.13* Hgb-11.4* Hct-34.4* MCV-83 MCH-27.6 MCHC-33.1 RDW-15.7* Plt Ct-350 [**2168-5-11**] 05:20AM BLOOD WBC-7.3 RBC-3.96* Hgb-10.4* Hct-33.3* MCV-84 MCH-26.1* MCHC-31.1 RDW-15.7* Plt Ct-338 [**2168-5-12**] 05:25AM BLOOD WBC-8.9 RBC-3.71* Hgb-9.9* Hct-30.9* MCV-83 MCH-26.7* MCHC-32.0 RDW-15.4 Plt Ct-311 [**2168-5-16**] 08:20PM BLOOD WBC-13.4*# RBC-3.75* Hgb-9.8* Hct-32.4* MCV-86 MCH-26.2* MCHC-30.4* RDW-15.7* Plt Ct-197 [**2168-5-17**] 02:24AM BLOOD WBC-11.8* RBC-3.70* Hgb-9.7* Hct-32.4* MCV-87 MCH-26.1* MCHC-29.9* RDW-15.9* Plt Ct-201 [**2168-5-18**] 02:11AM BLOOD WBC-13.6* RBC-3.57* Hgb-9.7* Hct-31.9* MCV-90 MCH-27.1 MCHC-30.3* RDW-16.3* Plt Ct-189 [**2168-5-19**] 03:24AM BLOOD WBC-12.1* RBC-3.31* Hgb-8.9* Hct-29.4* MCV-89 MCH-26.9* MCHC-30.3* RDW-16.4* Plt Ct-188 [**2168-5-20**] 05:31AM BLOOD WBC-9.5 RBC-3.14* Hgb-8.2* Hct-26.5* MCV-84 MCH-26.1* MCHC-31.0 RDW-16.3* Plt Ct-209 [**2168-5-21**] 05:10AM BLOOD WBC-8.5 RBC-3.27* Hgb-8.7* Hct-28.5* MCV-87 MCH-26.6* MCHC-30.5* RDW-16.5* Plt Ct-210 [**2168-5-22**] 06:45AM BLOOD WBC-12.1* RBC-3.25* Hgb-8.4* Hct-27.6* MCV-85 MCH-25.7* MCHC-30.3* RDW-16.1* Plt Ct-223 [**2168-5-10**] 04:50PM BLOOD Glucose-86 UreaN-17 Creat-0.9 Na-138 K-4.1 Cl-97 HCO3-26 AnGap-19 [**2168-5-11**] 05:20AM BLOOD Glucose-113* UreaN-15 Creat-0.9 Na-136 K-4.2 Cl-96 HCO3-29 AnGap-15 [**2168-5-12**] 05:25AM BLOOD Glucose-190* UreaN-15 Creat-1.0 Na-135 K-4.3 Cl-98 HCO3-28 AnGap-13 [**2168-5-13**] 06:39AM BLOOD Glucose-154* UreaN-20 Creat-1.0 Na-138 K-4.2 Cl-102 HCO3-26 AnGap-14 [**2168-5-15**] 05:26AM BLOOD Glucose-151* UreaN-27* Creat-0.9 Na-136 K-4.6 Cl-108 HCO3-21* AnGap-12 [**2168-5-16**] 08:20PM BLOOD Glucose-268* UreaN-28* Creat-1.0 Na-132* K-5.3* Cl-107 HCO3-19* AnGap-11 [**2168-5-17**] 02:24AM BLOOD Glucose-252* UreaN-29* Creat-1.0 Na-132* K-5.5* Cl-108 HCO3-21* AnGap-9 [**2168-5-18**] 02:11AM BLOOD Glucose-219* UreaN-29* Creat-0.9 Na-132* K-4.6 Cl-108 HCO3-17* AnGap-12 [**2168-5-19**] 03:24AM BLOOD Glucose-151* UreaN-34* Creat-1.0 Na-133 K-4.7 Cl-107 HCO3-18* AnGap-13 [**2168-5-20**] 05:31AM BLOOD Glucose-111* UreaN-35* Creat-1.0 Na-133 K-4.7 Cl-105 HCO3-22 AnGap-11 [**2168-5-21**] 05:10AM BLOOD Glucose-138* UreaN-32* Creat-0.7 Na-136 K-4.4 Cl-105 HCO3-22 AnGap-13 [**2168-5-22**] 06:45AM BLOOD Glucose-128* UreaN-36* Creat-0.8 Na-137 K-5.1 Cl-106 HCO3-24 AnGap-12 [**2168-5-10**] 04:50PM BLOOD ALT-11 AST-33 AlkPhos-184* TotBili-0.9 [**2168-5-11**] 05:20AM BLOOD ALT-10 AST-29 AlkPhos-167* TotBili-1.0 [**2168-5-12**] 05:25AM BLOOD ALT-28 AST-93* AlkPhos-284* TotBili-2.6* [**2168-5-13**] 06:39AM BLOOD ALT-28 AST-72* AlkPhos-236* TotBili-1.7* [**2168-5-14**] 06:00AM BLOOD ALT-25 AST-54* AlkPhos-226* TotBili-1.1 [**2168-5-16**] 08:20PM BLOOD ALT-44* AST-80* CK(CPK)-69 AlkPhos-299* TotBili-1.1 [**2168-5-18**] 02:11AM BLOOD ALT-36 AST-50* AlkPhos-197* TotBili-0.6 [**2168-5-19**] 03:24AM BLOOD ALT-31 AST-49* AlkPhos-168* TotBili-0.5 [**2168-5-20**] 05:31AM BLOOD ALT-31 AST-46* AlkPhos-177* TotBili-0.7 [**2168-5-22**] 06:45AM BLOOD ALT-32 AST-38 AlkPhos-247* TotBili-0.5  GALL BLADDER ASPIRATE.
FLUID CULTURE (Final [**2168-5-15**]):       ENTEROCOCCUS SP..
|          | AMPICILLIN------------  =>32 R     =>32 R LINEZOLID-------------     2 S        2 S PENICILLIN G----------    32 R     =>64 R VANCOMYCIN------------  =>32 R     =>32 R     ANAEROBIC CULTURE (Final [**2168-5-15**]):    NO ANAEROBES ISOLATED.
Her laboratory values were notable only for an elevated INR to 5.5 for which she received 10mg Vit K in preparation for IR procedures the ensuing day.
on [**2168-5-11**], Ms. [**Known lastname 91793**] [**Last Name (Titles) 1834**] a pullback cholangiogram with replacement of her 8Fr biliary catheters.
Common bile duct brushings were obtained and were notable for atypical glandular cells on cytology.
An omental node was sent for pathology, the results of which were notable for metastatic, well differentiated adenocarcinoma consistent with pancreaticobiliary origin.
Her PTBDs remain in place and are capped, with no rise in her LFTs noted.
Her INR is to be checked on [**2168-5-26**].
5. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization [**Month/Day (2) **]: One (1) inh Inhalation Q6H (every 6 hours) as needed for wheeze.
6. ipratropium bromide 0.02 % Solution [**Month/Day (2) **]: One (1) inh Inhalation Q6H (every 6 hours) as needed for wheezing.
Sodium Chloride 0.9%  Flush 3 mL IV Q8H:PRN line flush Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
12. ondansetron HCl (PF) 4 mg/2 mL Solution [**Month/Day (2) **]: One (1) Injection Q8H (every 8 hours) as needed for nausea.
Outpatient [**Name (NI) **] Work PT/INR Thursday [**5-26**] then twice weekly 16. oxycodone 5 mg/5 mL Solution [**Month/Year (2) **]: 5-10 mg PO Q4H (every 4 hours) as needed for pain: break thru pain give via J tube only monitor for sedation.
You [**Location (un) 1834**] a repeat biliary biopsy with brushings on [**2168-5-11**], the results of which were non-diagnostic.
You will need frequent blood checks to ensure that your INR is not too high.
Followup Instructions: You will be contact[**Name (NI) **] while in rehab by [**Name (NI) 698**] [**Last Name (NamePattern1) 699**], RN [**Telephone/Fax (1) 17195**] regarding follow up with Dr. [**Last Name (STitle) **]  - interventional radiology for internalization of your biliary drains - gastroenterology for placement of a duodenal stent - oncology for discussion regarding chemotherapy options  [**First Name4 (NamePattern1) 698**] [**Last Name (NamePattern1) 699**], RN coordinator for Dr. [**Last Name (STitle) **] [**Telephone/Fax (1) 673**] will call with follow up appointment in clinic for routine post-operative check in next 1-2 weeks                                [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**] MD, [**MD Number(3) 709**]  Completed by:[**2168-5-24**
